/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

RenovoRx Inc Share Price Today: Live Updates & Key Insights

RenovoRx Inc share price today is $0.9899, up -0.99%. The stock opened at $1.02 against the previous close of $1.01, with an intraday high of $1.03 and low of $0.97495.

RenovoRx Inc Share Price Chart

style
pb-0

RenovoRx Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

RenovoRx Inc Share Price Performance

$0.9899 -0.0099(-0.99%) RNXT at 23 Mar 2026 03:03 PM Biotechnology
Lowest Today 0.97495
Highest Today 1.03
Today’s Open 1.02
Prev. Close 1.01
52 Week High 1.45
52 Week Low 0.70
Day’s Range: Low 0.97495 High 1.03
52-Week Range: Low 0.70 High 1.45
1 day return -
1 Week return +2.21
1 month return +9.4
3 month return +11.39
6 month return -23.66
1 year return -5.66
3 year return -61.24
5 year return -86.66
10 year return -

RenovoRx Inc Institutional Holdings

AIGH Capital Management, LLC 7.73

Vanguard Group Inc 4.38

Vanguard Total Stock Mkt Idx Inv 2.82

Bleichroeder LP 1.64

Vanguard Institutional Extnd Mkt Idx Tr 1.04

Geode Capital Management, LLC 1.01

Fidelity Extended Market Index 0.49

Renaissance Technologies Corp 0.32

Watch Point Trust Co 0.27

Chicago Partners Investment Group LLC 0.25

Susquehanna International Group, LLP 0.25

Fidelity Total Market Index 0.21

Northwestern Mutual Wealth Management Co 0.20

Caprock Group Inc 0.17

Citadel Advisors Llc 0.15

Fidelity Series Total Market Index 0.14

Northern Trust Corp 0.12

Kestra Advisory Services, LLC 0.10

Spartan Extended Market Index Pool F 0.09

Vanguard Balanced Index Inv 0.09

XTX Topco Ltd 0.09

State Street Corp 0.07

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - L 0.07

Spartan Total Market Index Pool G 0.06

Vanguard Instl Ttl Stck Mkt Idx Tr 0.06

Cypress Point Wealth Management, LLC 0.05

HighTower Advisors, LLC 0.05

TWO SIGMA SECURITIES, LLC 0.05

NT Ext Equity Mkt Idx Fd - NL 0.04

Jane Street Group LLC 0.04

Ground Swell Capital, LLC 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.03

State St US Extended Mkt Indx NL Cl C 0.02

Fidelity Nasdaq Composite Index 0.02

SSgA U.S. Total Market Index Strategy 0.01

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

RenovoRx Inc Market Status

Strong Buy: 2

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

RenovoRx Inc Fundamentals

Market Cap 36.65 M

PB Ratio 4.537

PE Ratio 0.0

Enterprise Value 26.84 M

Total Assets 8.12 M

Volume 276540

RenovoRx Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-9161000 -9.2M, FY22:-9771000 -9.8M, FY21:-7096000 -7.1M, FY20:-4385000 -4.4M, FY19:-3776000 -3.8M

Quarterly Revenue Q3/2025:266000 0.3M, Q2/2025:422000 0.4M, Q1/2025:197000 0.2M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:213000 0.2M, Q2/2025:270000 0.3M, Q1/2025:103000 0.1M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-2912000 -2.9M, Q2/2025:-2895000 -2.9M, Q1/2025:-2420000 -2.4M, Q3/2024:-2471000 -2.5M, Q2/2024:-2389000 -2.4M

About RenovoRx Inc & investment objective

Company Information RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.

Organisation Biotechnology

Employees 10

Industry Biotechnology

CEO Mr. Shaun R. Bagai

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

RenovoRx Inc FAQs

What is the share price of RenovoRx Inc today?

The current share price of RenovoRx Inc is $0.9899.

Can I buy RenovoRx Inc shares in India?

Yes, Indian investors can buy RenovoRx Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy RenovoRx Inc shares in India?

You can easily invest in RenovoRx Inc shares from India by:

Can I buy fractional shares of RenovoRx Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of RenovoRx Inc?

RenovoRx Inc has a market cap of $36.65 M.

In which sector does RenovoRx Inc belong?

RenovoRx Inc operates in the Biotechnology sector.

What documents are required to invest in RenovoRx Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of RenovoRx Inc?

The PE ratio of RenovoRx Inc is N/A and the PB ratio is 4.54.